Mutya, Norberto G.
HRN: 22-99-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
CEFTRIAXONE 1G (VIAL)
04/30/2023
05/06/2023
IV
2g
OD
Complicated UTI; CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes